Ge healthcare announces $80 million investment to expand contrast media production capacity

Spangereid, norway--( business wire )--ge healthcare's pharmaceutical diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its active pharmaceutical ingredients (api) site in lindesnes, norway. the investment – which is creating around 100 new jobs – is part of ge healthcare's broader commitment to address significant future global demand for iodinated contrast media, used in xray and computed tomography (ct) procedures around the world to enhance visualization of organs, blood vessels and tissues across disease pathways.
GE Ratings Summary
GE Quant Ranking